DIR reform reduces patient cost sharing for medications.
Reforming pharmacy DIR fees will save patients $7.1 to $9.2 billion over 10 years.
DIR reform increases the likelihood that patients take their medications as prescribed.
A review of 160 studies revealed that medication adherence significantly decreases as the medication cost to the patient increases.
DIR reform allows patients to stay healthier, and avoid more costly care.
Disease-specific cost of non-adherence is estimated up to $44,190 per person, and costs attributed to ʻall causesʼ non-adherence is estimated up to $52,341 per person.
DIR reform lowers overall healthcare costs, saving the federal government money.
If 25% of hypertension patients who were non-adherent became adherent, Medicare could save nearly $14 billion annually, averting over 100,000 emergency room visits and 7 million inpatient hospital days.